Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex

SummaryThe antidepressant drug clomipramine (CIM) blocks 5-hydroxytryptamine (5-HT) uptake in vitro. Electrophysiological studies have shown that CIM also reduces the firing of serotonergic neurons in the dorsal raphe nucleus. In order to assess the effects of CIM on serotonergic transmission in vivo, the technique of intracerebral microdialysis was used. CIM was administered either through the dialysis probe or i. p., and dialysate 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) were determined in frontal cortex and/or raphe nuclei. In addition, the action of extracellular 5-HT in raphe nuclei on the release of 5-HT in frontal cortex was studied.The administration of CIM through the dialysis probe increased dialysate 5-HT in frontal cortex in a dose-dependent fashion. An actual ED50 of 3.15 μM CIM for the in vivo inhibition of 5-HT uptake can be calculated in this brain area. When given systemically (10 or 20 mg/kg i. p.), CIM did not increase dialysate 5-HT in the frontal cortex. The occurrence of extracellular 5-HT in the raphe area was demonstrated. This pool of 5-HT increased markedly after local (10 or 40 μM) or systemic (20 mg/kg i. p.) administration of CIM. We also examined the effect of CIM applied locally in the raphe nuclei on extracellular 5-HT in the frontal cortex. The increased dialysate 5-HT in raphe after 10 or 40 μM CIM paralleled a decrease of dialysate 5-HT in the frontal cortex. Values of dialysate 5-HT in the two areas correlated negatively. The administration of CIM through the dialysis probe slightly decreased dialysate 5-HIAA in the frontal cortex. When given systemically, CIM also decreased dialysate 5-HIAA in the frontal cortex, but significantly only after the highest dose tested (20 mg/kg i.p.). Furthermore, the local application of CIM into the raphe nuclei produced a decrease of dialysate 5-HIAA in the frontal cortex.These results prove the in vivo inhibitory activity of CIM on 5-HT uptake. This effect is much more pronounced in the raphe nuclei than in the frontal cortex when CIM is given systemically. However, both areas are equally sensitive to the local application of the drug. The effect of CIM on raphe nuclei partly antagonizes that on the frontal cortex, providing evidence for a functional link between these two brain regions.

[1]  A. Pletscher,et al.  Blood platelets as models for neurons: uses and limitations. , 1980, Journal of neural transmission. Supplementum.

[2]  C. Montigny,et al.  Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: Single-cell studies in the rat , 2004, Psychopharmacology.

[3]  G. Aghajanian,et al.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists , 1987, Synapse.

[4]  C. de Montigny,et al.  Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression , 1987, Journal of clinical psychopharmacology.

[5]  G. Chiara,et al.  Serotonin release estimated by transcortical dialysis in freely-moving rats , 1989, Neuroscience.

[6]  F. Artigas,et al.  Evaluation of the potential of thermospray liquid chromatography-mass spectrometry in neurochemistry. , 1987, Journal of chromatography.

[7]  B. Haber,et al.  Uptake of biogenic amines by glial cells in culture I. A neuronal-like transport system for serotonin. , 1978, Life sciences.

[8]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[9]  F Benfenati,et al.  Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Cooper,et al.  Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. , 1983, The Journal of pharmacology and experimental therapeutics.

[11]  B. Koe Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.

[12]  H. Lôo,et al.  Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers: Comparison with maprotiline and amineptine , 1987, Biological Psychiatry.

[13]  G. Aghajanian,et al.  Rophe neurons: effect of tricyclic antidepressant drugs. , 1972, Brain research.

[14]  Bramwell Gj The effect of antidepressants on unit activity in the midbrain raphé of rats. , 1974 .

[15]  J. Scuvée-Moreau,et al.  Effect of trazodone on the firing rate of central monoaminergic neurons. Comparison with various antidepressants. , 1982, Archives internationales de pharmacodynamie et de therapie.

[16]  S. Z. Langer,et al.  A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter. , 1989, Biochemical pharmacology.

[17]  Aghajanian Gk Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. , 1978 .

[18]  M. Hamon,et al.  [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain , 1985, Journal of neurochemistry.

[19]  J. Scuvée-Moreau,et al.  Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; Correlation with reduction of spontaneous firing rate of central monoaminergic neurones , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  D. Wong,et al.  Inhibition of serotonin reuptake. , 1977, Federation proceedings.

[21]  P. Mantegazza,et al.  Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: Similarities and differences , 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  G. Aghajanian,et al.  Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effects of LSD , 1982, Brain Research.

[23]  C. Montigny,et al.  Electrophysiologically-identified serotonin receptors in the rat CNS Effect of antidepressant treatment , 1984, Neuropharmacology.

[24]  G. Chiara In-vivo brain dialysis of neurotransmitters , 1990 .

[25]  J. Lakoski,et al.  The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[26]  A. Armario,et al.  Chronic administration of clomipramine prevents the increase in serotonin and noradrenaline induced by chronic stress , 2004, Psychopharmacology.

[27]  H. Yamamura,et al.  Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.

[28]  J. Scuvée-Moreau,et al.  ACTION OF ANTIDEPRESSANTS ON THE SPONTANEOUS FIRING OF LOCUS COERULEUS AND DORSAL RAPHE NEURONS OF THE RAT , 1979 .

[29]  P. Hutson,et al.  An in vivo dialysis and behavioural study of the release of 5‐HT by p‐chloroamphetamine in reserpine‐treated rats , 1989, British journal of pharmacology.

[30]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[31]  H. Hall,et al.  Effects of antidepressant drugs on different receptors in the brain. , 1981, European journal of pharmacology.

[32]  J. A. Nielsen,et al.  Chlorimipramine, fenfluramine and quipazine decrease 5-hydroxytryptamine synthesis in discrete rat brain nuclei , 1986, Neurochemistry International.

[33]  C. Montigny,et al.  Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  G Di Chiara,et al.  In-vivo brain dialysis of neurotransmitters. , 1990, Trends in pharmacological sciences.

[35]  J. Korf,et al.  Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment , 1977, Psychopharmacology.

[36]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[37]  D. Straughan,et al.  Proceedings: Effect of imipramine on unit activity in the midbrain raphé of rats. , 1972, British journal of pharmacology.

[38]  M. Hamon,et al.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.

[39]  A. Greenshaw,et al.  Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats , 2005, Journal of Neural Transmission.

[40]  G. Aghajanian,et al.  Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow. , 1975, The Journal of pharmacology and experimental therapeutics.

[41]  S. Hjorth,et al.  The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[42]  Yves Chaput,et al.  Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[43]  P. H. Hutson,et al.  Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis , 1989, Neuroscience Letters.

[44]  I. Martin,et al.  The effects of some indolalkylamines on the uptake and release of 5-hydroxytryptamine in rat striatum [proceedings]. , 1977, British Journal of Pharmacology.

[45]  M. F. Sugrue Current concepts of the mechanisms of action of antidepressant drugs. , 1981, Pharmacology & therapeutics.